Although Indian pharma stocks fell in early trade, analysts called it a “kneejerk reaction” driven by the ambiguity of the announcement and its uncertain timeline.
Although Indian pharma stocks fell in early trade, analysts called it a “kneejerk reaction” driven by the ambiguity of the announcement and its uncertain timeline. by Soban News (international And National News)
